Clinical Trial Update: Different First-line Immunotherapy for Advancer Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune Microenvironment

View source ↗

Summary

A prospective observational study evaluating different first-line immunotherapies for advanced hepatocellular carcinoma, focusing on efficacy and the immune mic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Fudan University | Conditions: Advanced Hepatocellular Carcinoma (HCC) | Status: RECRUITING